Why Cell Therapy Visibility Must Start at Patient Enrollment – Not Manufacturing
In many cell therapy programs, visibility is often viewed as a manufacturing responsibility. Where …
How Connected MES Modules Reduce FDA Audit Preparation from Weeks to Hours in GMP Environments
When regulators request the history of a single batch, the clock starts immediately. In many cell …
Why Freezer Inventory Becomes the Third Module in the MES Journey for Cell Therapy
In cell and gene therapy, the moment a batch is completed is not the end of the process. In many …
When Batch Records Meet Scheduling: The Hidden Intelligence Transforming GMP Operations
Most organizations assume MES value is additive. Implement Electronic Batch Records (EBR), and …
Why Production Scheduling Is Often the Second Module Organizations Implement After Electronic Batch Records
Organizations implementing Electronic Batch Records (EBR) often see immediate improvements. Batch …
How Electronic Batch Records Reduce QA Review Time from Hours to Minutes
6 hours to review a batch record. 5 hours and 45 minutes spent confirming nothing went wrong. For …
How Modular Software Enables 4-6 Month Implementation in Cell & Gene Therapy
In cell and gene therapy (CGT), speed matters. Not just for operational efficiency. But for …
Workflow Orchestration: Why Executing Steps in the Right Sequence Matters for GMP Compliance
In cell therapy manufacturing, progress isn’t just about moving faster. It’s about …
How MES Helps Ensure GMP Compliance in Manufacturing
In regulated manufacturing, compliance is often treated as a checklist. A set of SOPs to follow. A …
